series-a
Stage
2023
Founded
1
Investors
About
Elevara Medicines is a clinical-stage biotech company focused on developing therapies for rheumatoid arthritis and chronic inflammatory diseases, specifically targeting fibroblast-like synoviocytes to overcome the limitations of existing immunosuppressive treatments.
Explore Elevara Medicines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.